Healthconn Corp. (TPEX:6665)
Taiwan · Delayed Price · Currency is TWD 18.15
0.00 (0.00%)
Aug 19, 2026, 10:03 AM CST
Healthconn Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,174 | 1,131 | 1,253 | 1,256 | 1,545 | 1,363 |
Revenue Growth | 3.76% | -9.76% | -0.20% | -18.73% | 13.38% | -9.57% |
Gross Profit Gross Profit Growth | 227.24 | 203.94 | 238.86 | 245.45 | 312.68 | 313.62 |
Operating Income Operating Income Growth | 16.79 | 3.32 | 12.06 | 2.95 | 60.86 | 52.35 |
Net Income Net Income Growth | 21.49 | 8.39 | 19.23 | 2.36 | 25.44 | 37.43 |
Earnings Per Share EPS Growth | 0.49 | 0.19 | 0.42 | 0.05 | 0.56 | 0.83 |
EPS Growth | 162.80% | -55.93% | 740.00% | -91.07% | -32.53% | -67.95% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Health Management Services and Genetic Testing Sales Health Management Services and Genetic Testing Sales Growth | 52.73 | 52.73 | 154.94 | - | - | - |
Medical equipment integration agent Medical equipment integration agent Growth | 1,078 | 1,078 | 1,098 | 1,045 | 1,014 | 906.26 |
Total Total Growth | 1,131 | 1,131 | 1,253 | 1,256 | 1,545 | 1,363 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 356.02 | 395.53 | 623.49 | 779.52 | 831.67 | 901.22 |
Total Debt Total Debt Growth | 435.68 | 276.31 | 306.03 | 364.33 | 348.48 | 508.6 |
Net Cash (Debt) Net Cash Growth | -79.65 | 119.22 | 317.47 | 415.19 | 483.19 | 392.62 |
Net Cash Growth | - | -62.44% | -23.54% | -14.07% | 23.07% | -27.87% |
Net Cash Per Share Net Cash Per Share Growth | -1.80 | 2.63 | 7.00 | 9.15 | 10.65 | 8.67 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 24.55 | 66.78 | 17.31 | 62.84 | 166.87 | 85.4 |
Capital Expenditures CapEx Growth | -101.85 | -23.67 | -17.14 | -7.55 | -69.18 | -25.96 |
Free Cash Flow Free Cash Flow Growth | -77.3 | 43.1 | 0.17 | 55.29 | 97.69 | 59.45 |
Free Cash Flow Growth | - | 25255.88% | -99.69% | -43.40% | 64.34% | -79.92% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 19.36% | 18.03% | 19.06% | 19.55% | 20.23% | 23.01% |
Operating Margin | 1.43% | 0.29% | 0.96% | 0.24% | 3.94% | 3.84% |
Pretax Margin | 2.82% | 1.43% | 2.05% | 1.30% | 4.55% | 4.93% |
Profit Margin | 1.83% | 0.74% | 1.53% | 0.19% | 1.65% | 2.75% |
FCF Margin | -6.59% | 3.81% | 0.01% | 4.40% | 6.32% | 4.36% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.148 | 0.148 | 0.700 | 0.050 | 0.450 | 0.700 |
Dividend Per Share Growth | -78.83% | -78.82% | 1300.00% | -88.89% | -35.71% | -68.89% |
Dividend Yield | 0.81% | 0.74% | 3.95% | 0.18% | 1.36% | 1.56% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 37.31 | 108.32 | 43.40 | 548.36 | 62.30 | 57.90 |
P/FCF Ratio | - | 21.09 | 4908.48 | 23.38 | 16.22 | 36.46 |
PS Ratio | 0.70 | 0.80 | 0.67 | 1.03 | 1.03 | 1.59 |